Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G T Budd

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Cancer Research|November 15, 1990
Phase I trial of dipyridamole with 5-fluorouracil and folinic acidG T Budd, A Jayaraj, D Grabowski, et al.
Journal of Cancer Research and Clinical Oncology|May 18, 2001
Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinomaT Olencki, D Peereboom, L Wood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosisS A Vaziri, L M Krumroy, P Elson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Phase I trial of high-dose bolus interleukin-2 and interferon alfa-2a in patients with metastatic malignancyG T Budd, S Murthy, J Finke, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
A phase I trial of intrapleural recombinant human interferon alpha (rHuIFN alpha 2b) in patients with malignant pleural effusionsA Bhatia, T W Rice, D McLain, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 23, 2000
Phase 1 trial of subcutaneous IL-6 in patients with refractory cancer: clinical and biologic effectsT Olencki, J Finke, R Tubbs, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2000
A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancerR Pelley, R Ganapathi, L Wood, et al.
Cancer|March 15, 1996
Phase II trial of subcutaneously administered granulocyte-macrophage colony-stimulating factor in patients with metastatic renal cell carcinomaE Wos, T Olencki, L Tuason, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trialR L Miller, R M Bukowski, G T Budd, et al.
Journal of Biological Response Modifiers|December 1, 1990
Phase I trial of continuous infusion recombinant interleukin-2 and intermittent recombinant interferon-alpha 2a: clinical effectsR M Bukowski, S Murthy, J Sergi, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Cancer Research|November 15, 1990
Phase I trial of dipyridamole with 5-fluorouracil and folinic acidG T Budd, A Jayaraj, D Grabowski, et al.
Journal of Cancer Research and Clinical Oncology|May 18, 2001
Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinomaT Olencki, D Peereboom, L Wood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosisS A Vaziri, L M Krumroy, P Elson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Phase I trial of high-dose bolus interleukin-2 and interferon alfa-2a in patients with metastatic malignancyG T Budd, S Murthy, J Finke, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
A phase I trial of intrapleural recombinant human interferon alpha (rHuIFN alpha 2b) in patients with malignant pleural effusionsA Bhatia, T W Rice, D McLain, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 23, 2000
Phase 1 trial of subcutaneous IL-6 in patients with refractory cancer: clinical and biologic effectsT Olencki, J Finke, R Tubbs, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2000
A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancerR Pelley, R Ganapathi, L Wood, et al.
Cancer|March 15, 1996
Phase II trial of subcutaneously administered granulocyte-macrophage colony-stimulating factor in patients with metastatic renal cell carcinomaE Wos, T Olencki, L Tuason, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trialR L Miller, R M Bukowski, G T Budd, et al.
Journal of Biological Response Modifiers|December 1, 1990
Phase I trial of continuous infusion recombinant interleukin-2 and intermittent recombinant interferon-alpha 2a: clinical effectsR M Bukowski, S Murthy, J Sergi, et al.
Pageof 7